Moleculin Biotech Inc (MBRX) Stock Price, Quote, News & History

MBRXNASDAQ
$0.7731
-0.0069-0.88%
At close: Sep 18, 5:00 PM EST
$0.7300
-0.0431-5.57%
After Hours: 7:53 PM EST

Moleculin Biotech (MBRX) Stock Price, Quote, News & History | Benzinga

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.36M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
25.09M
Free Cash Flow (TTM)
-25.36M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-270.00K

Analyst Trends and Forecast

1
Mar
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$7.98M
PE Ratio (TTM)
0.05
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.30
Earnings Yield % (TTM)
1883.80%
Earnings Yield % (FWD)
-154.94%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.59

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$7.26M
Debt to Equity
0.03
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.78
Close
$0.77
Volume / Avg.
466.34K / 1.30M
Day Range
$0.75 - $0.80
52 Wk Range
0.16 - 15.74
Market Cap
$14.22M
P/E Ratio
0.05
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
0.92%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cance...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Moleculin Biotech (MBRX) stock?

A

You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Moleculin Biotech (MBRX) competitors?

Q

What is the forecast, or price target, for Moleculin Biotech (MBRX) stock?

A

Moleculin Biotech has a consensus price target of $100.75.

Q

What is the current price for Moleculin Biotech (MBRX)?

A

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $0.73 last updated September 18, 2026 at 7:53 PM EDT.

Q

Does Moleculin Biotech (MBRX) pay a dividend?

A

There are no upcoming dividends for Moleculin Biotech.

Q

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

A

Moleculin Biotech does not have any upcoming earnings scheduled.

Q

Is Moleculin Biotech (MBRX) going to split?

A

There is no upcoming split for Moleculin Biotech.

Q

What sector and industry does Moleculin Biotech (MBRX) operate in?

A

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.